Dynavox Group ABFRA:H3Q +3.05%79 OCF Margin % is 18.20% as of Mar. 2026, which is 16% above its 10-year median of 15.67. GuruFocus rates FRA:H3Q with a GF Score™ of 79/100 and a GF Value™ of €7.82 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Dynavox Group AB ranks better than 56.99% on this metric.
The historical rank and industry rank for Dynavox Group AB's OCF Margin % or its related term are showing as below:
FRA:H3Q'
s OCF Margin % Range Over the Past 10 Years
Min: 7.91 Med: 15.67 Max: 30.44
Current: 9.56
During the past 7 years, the highest OCF Margin % of Dynavox Group AB was 30.44%. The lowest was 7.91%. And the median was 15.67%.
FRA:H3Q's OCF Margin % is ranked better than 56.99% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 5.84
vs FRA:H3Q: 9.56
Dynavox Group AB OCF Margin % Related Terms
Dynavox Group AB OCF Margin % Historical Data
* Premium members only.
The historical data trend for Dynavox Group AB's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:H3Q vs ISRG, BDX, MDLN: OCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Dynavox Group AB's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dynavox Group AB OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Dynavox Group AB's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Dynavox Group AB's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dynavox Group AB (FRA:H3Q) has a OCF Margin % of 18.20% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Dynavox Group AB and its competitors. This is 16% above median its historical median of 15.67. Over the past decade, Dynavox Group AB's OCF Margin % has ranged from 7.91 to 30.44. According to the industry distribution chart, Dynavox Group AB ranks #351 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 43%.
Is Dynavox Group AB's OCF Margin % too high?
Dynavox Group AB's current OCF Margin % of 18.20% is 16% above median its 10-year median of 15.67. Over the past 10 years, this metric has ranged from a low of 7.91 to a high of 30.44. The Medical Devices & Instruments industry median OCF Margin % is 5.84. Dynavox Group AB's value of 18.20% is 211.6% above this industry median. Based on the distribution chart, Dynavox Group AB ranks #351 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Dynavox Group AB has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dynavox Group AB's OCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Dynavox Group AB ranks #351 out of 816 companies for OCF Margin %. This puts Dynavox Group AB in the upper half of its industry. The industry median OCF Margin % is 5.84. Dynavox Group AB's value of 18.20% is 211.6% above this benchmark. Historically, Dynavox Group AB's own OCF Margin % has ranged from 7.91 to 30.44 over the past decade. While the company's 10-year median is 15.67 vs. the industry median of 5.84, Dynavox Group AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.84, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dynavox Group AB's current OCF Margin % of 18.20% is 211.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Dynavox Group AB and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dynavox Group AB's current OCF Margin % is 18.20%, which is 16% above median its own 10-year median of 15.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dynavox Group AB stock overvalued right now?
Based on GuruFocus' analysis, Dynavox Group AB (FRA:H3Q) is currently considered Modestly Undervalued. The stock's GF Value™ is €7.82, compared to a current price of €5.75 — trading 26.5% below its estimated fair value. The current OCF Margin % is 18.20%, which is 16% above median its 10-year median of 15.67 and 211.6% above the Medical Devices & Instruments industry median of 5.84. Dynavox Group AB's overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Dynavox Group AB (FRA:H3Q), the current OCF Margin % is 18.20% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dynavox Group AB (FRA:H3Q) Overvalued in 2026?
Based on GuruFocus' analysis, Dynavox Group AB stock appears to be undervalued.
The current stock price of €5.75 is trading 26.5% below its estimated GF Value™ of €7.82.
GuruFocus considers Dynavox Group AB to be Modestly Undervalued.
Key valuation signals for FRA:H3Q:
OCF Margin %: 18.20% (16% above median its 10-year median of 15.67)
GF Value™: €7.82 vs. price of €5.75 (26.5% below fair value)
Industry Position: 211.6% above the Medical Devices & Instruments median (#351 of 816)
No single metric tells the full story. See the FRA:H3Q stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dynavox Group AB is engaged in assistive technology for communication. The company's Augmentative and Alternative Communication (AAC) solutions enable people with disabilities such as cerebral palsy, ALS, and spinal cord injury to communicate with a voice of their own, develop literacy skills, and live more independently. The company is a comprehensive SaaS provider with local roots. The company operates in Europe, North America, and Other countries, with the majority of revenue from North America.
79GF Score
Get the complete analysis for FRA:H3Q
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:H3Q has been successfully added to your 
